BENICZKY, S., S. WIEBE, J. JEPPESEN, W.O. TATUM, Milan BRÁZDIL, Y.P. WANG, S.T. HERMAN and P. RYVLIN. Automated seizure detection using wearable devices: A clinical practice guideline of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology. Epilepsia. Hoboken: Wiley-Blackwell, 2021, vol. 62, No 3, p. 632-646. ISSN 0013-9580. Available from: https://dx.doi.org/10.1111/epi.16818.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Automated seizure detection using wearable devices: A clinical practice guideline of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology
Authors BENICZKY, S. (guarantor), S. WIEBE, J. JEPPESEN, W.O. TATUM, Milan BRÁZDIL (203 Czech Republic, belonging to the institution), Y.P. WANG, S.T. HERMAN and P. RYVLIN.
Edition Epilepsia, Hoboken, Wiley-Blackwell, 2021, 0013-9580.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30210 Clinical neurology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 6.740
RIV identification code RIV/00216224:14110/21:00124311
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1111/epi.16818
UT WoS 000625480200007
Keywords in English algorithms; automated detection; epilepsy; seizure detection; wearable devices
Tags 14110127, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 19/4/2022 10:24.
Abstract
The objective of this clinical practice guideline (CPG) is to provide recommendations for healthcare personnel working with patients with epilepsy on the use of wearable devices for automated seizure detection in patients with epilepsy, in outpatient, ambulatory settings. The Working Group of the International League Against Epilepsy (ILAE) and the International Federation of Clinical Neurophysiology (IFCN) developed the CPG according to the methodology proposed by the ILAE Epilepsy Guidelines Working Group. We reviewed the published evidence using The Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) statement and evaluated the evidence and formulated the recommendations following the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. We found high level of evidence for the accuracy of automated detection of generalized tonic-clonic seizures (GTCS) and focal-to-bilateral tonic-clonic seizures (FBTCS) and recommend the use of wearable automated seizure detection devices for selected patients when accurate detection of GTCS and FBTCS is recommended as a clinical adjunct. We also found a moderate level of evidence for seizure types without GTCS or FBTCS. However, it was uncertain whether the detected alarms resulted in meaningful clinical outcomes for the patients. We recommend using clinically validated devices for automated detection of GTCS and FBTCS, especially in unsupervised patients, where alarms can result in rapid intervention (weak/conditional recommendation). At present, we do not recommend clinical use of the currently available devices for other seizure types (weak/conditional recommendation). Further research and development are needed to improve the performance of automated seizure detection and to document their accuracy and clinical utility.
PrintDisplayed: 25/4/2024 09:54